EKF Diagnostics Holdings plc

OTCPK:EKDH.F Stock Report

Market Cap: US$161.7m

EKF Diagnostics Holdings Past Earnings Performance

Past criteria checks 4/6

EKF Diagnostics Holdings's earnings have been declining at an average annual rate of -25.9%, while the Medical Equipment industry saw earnings growing at 14.9% annually. Revenues have been declining at an average rate of 2.4% per year. EKF Diagnostics Holdings's return on equity is 9%, and it has net margins of 12.4%.

Key information

-25.87%

Earnings growth rate

-25.87%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth rate-2.42%
Return on equity8.98%
Net Margin12.44%
Last Earnings Update31 Dec 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How EKF Diagnostics Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:EKDH.F Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 24506141
30 Sep 24516132
30 Jun 24515122
31 Mar 24524132
31 Dec 23532142
30 Sep 2354-5142
30 Jun 2356-13142
31 Mar 2361-11152
31 Dec 2267-10162
30 Sep 2274-1171
30 Jun 22819171
31 Mar 228112141
31 Dec 218216111
30 Sep 218016131
30 Jun 217716151
31 Mar 217114161
31 Dec 206511171
30 Sep 20589142
30 Jun 20506122
31 Mar 20475122
31 Dec 19454132
30 Sep 19447122
30 Jun 194411122
31 Mar 194310122
31 Dec 184310122
30 Sep 18417132
30 Jun 18404132
31 Mar 18413142
31 Dec 17423142
30 Sep 17422132
30 Jun 17431133
31 Mar 17411123
31 Dec 16390113
30 Sep 1636-11164
30 Jun 1633-22215
31 Mar 1631-18165
31 Dec 1530-14115
30 Jun 1535440
31 Mar 1536090
31 Dec 1437-5140
30 Sep 1437-4160

Quality Earnings: EKDH.F has high quality earnings.

Growing Profit Margin: EKDH.F's current net profit margins (12.4%) are higher than last year (4.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EKDH.F's earnings have declined by 25.9% per year over the past 5 years.

Accelerating Growth: EKDH.F's earnings growth over the past year (165.4%) exceeds its 5-year average (-25.9% per year).

Earnings vs Industry: EKDH.F earnings growth over the past year (165.4%) exceeded the Medical Equipment industry 15.1%.


Return on Equity

High ROE: EKDH.F's Return on Equity (9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/22 05:49
End of Day Share Price 2025/07/18 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EKF Diagnostics Holdings plc is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Julie SimmondsCanaccord Genuity
Jens LindqvistInvestec Bank plc (UK)
Julie SimmondsPanmure Liberum